FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product unbuzzd
Portfolio Pulse from Benzinga Newsdesk
FSD Pharma announced that Celly Nu has entered into a strategic partnership with Six+One for the beverage product unbuzzd, which uses FSD Pharma's licensed technology to relieve the effects of alcohol. FSD Pharma will receive royalties from sales of products using this technology.
April 25, 2024 | 11:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
FSD Pharma's partnership with Celly Nu and Six+One for the beverage product unbuzzd could increase revenue through royalties, potentially boosting investor confidence.
The strategic partnership for the product unbuzzd involves FSD Pharma's licensed technology, which could lead to increased revenue through royalties. This partnership and the potential for increased sales could positively impact FSD Pharma's financials and investor sentiment in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90